logo

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Intellikine LLC

Calculating rank
USPTO Granted Patents = 34

% Expired Patents = 32.4



Forward Citations = 584

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Yi Liu (33 out of 153 patents)

silverMedal Pingda Ren (32 out of 141 patents)

bronzeMedal Troy Edward Wilson (31 out of 55 patents)

4.  Liansheng Li (27 out of 118 patents)

5.  Katrina Chan (25 out of 47 patents)

6.  Christian Rommel (16 out of 16 patents)

7.  Simon F Campbell (4 out of 52 patents)

8.  Michael Martin (3 out of 11 patents)

9.  Katayoun Jessen (3 out of 8 patents)

10.  Xin Guo (3 out of 7 patents)

11.  Lynne Bui (2 out of 4 patents)

12.  Andrew Gaheem Hsieh (1 out of 23 patents)

13.  Kevan M Shokat (1 out of 54 patents)

14.  Davide Ruggero (1 out of 4 patents)

15.  David Fruman (1 out of 1 patent)


Core Competencies:
Chemical Entities
Pharmaceutical Compositions
Kinase Inhibitors
mTOR Inhibitors
Heterocyclic Compounds
Isoquinolin-1(2H)-one
Benzothiazole
Benzoxazole
Quinazolines
PI3 Kinase Inhibitors
Polymorphs
Combination Therapies

34 patents:

1. 11433065 - Certain chemical entities, compositions and methods (2022-09-06),
2. 10172858 - Combination pharmaceutical compositions and uses thereof (2019-01-08),
3. 9828378 - Kinase inhibitors and methods of use (2017-11-28),
4. 9822131 - Certain chemical entities, compositions and methods (2017-11-21),
5. 9790228 - Heterocyclic kinase inhibitors (2017-10-17),
6. 9682141 - Combination of kinase inhibitors and uses thereof (2017-06-20),
7. 9669032 - Enhanced treatment regimens using mTOR inhibitors (2017-06-06),
8. 9655892 - Certain chemical entities, compositions and methods (2017-05-23),
9. 9637492 - Benzothiazole kinase inhibitors and methods of use (2017-05-02),
10. 9629843 - MTOR modulators and uses thereof (2017-04-25),
11. 9522146 - Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof (2016-12-20),
12. 9403820 - Kinase inhibitor polymorphs (2016-08-02),
13. 9359352 - Substituted benzimidazoles as PI3 kinase inhibitors (2016-06-07),
14. 9359349 - Substituted quinazolines as kinase inhibitors (2016-06-07),
15. 9345706 - Benzoxazole kinase inhibitors and methods of use (2016-05-24),
Company Overview
Intellikine LLC is a biotechnology company based in La Jolla, California, specializing in the development of innovative therapeutics targeting cancer and other serious diseases. The organization focuses on small molecule inhibitors that modulate key signaling pathways involved in disease progression. With a commitment to advancing medical research, Intellikine aims to provide novel treatment options that improve patient outcomes and enhance the understanding of complex biological systems.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

Intellikine LLC USPTO Patent Assignee Logo
34 Patents

#19 in La Jolla, CA

#2,382 in California

#10,020 in US

#19,697 in the World

La Jolla, CA (US)
La Jolla, CA, United States of America

Intellikine LLC

Forward Citations = 584

21 inventors:

goldMedal Yi Liu (33 out of 153 patents)

silverMedal Pingda Ren (32 out of 141 patents)

bronzeMedal Troy Edward Wilson (31 out of 55 patents)

4.  Liansheng Li (27 out of 118 patents)

5.  Katrina Chan (25 out of 47 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Intellikine LLC. Retrieved from https://idiyas.com/company/intellikine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…